Has Raun Melmed received payments from drug or device companies?

Yes. Drug and device makers reported $15,745 in general payments to Raun Melmed across 87 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Raun Melmed did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Raun Melmed come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Raun Melmed

Developmental - Behavioral Pediatrics · Scottsdale, AZNPI 1407876808

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $12,245 of the $15,745 with a category attached, or 77.8%. 10 manufacturers reported payments, led by Adlon Therapeutics L.p. at 54.3% of the total. Reporting peaked in 2019 at $10,192 and has fallen 99.6% since, to $42 in 2025.

$15,745in general payments, 2019–2025

Across 87 payments — averaging $180.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Adlon Therapeutics L.p.$9K
Takeda Pharmaceuticals U.S.A., Inc.$2K
Corium, LLC$2K
Roche Products Limited$1K
Tris Pharma Inc$564
Ironshore Pharmaceuticals Inc.$171
plus $282 from 4 others

$1,633,117in research payments, 2019–2025

Across 174 payments — averaging $9385.73 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Janssen Research & Development, LLC$804K
Acadia Pharmaceuticals Inc$587K
F. Hoffmann-la Roche AG$105K
Genentech, Inc.$76K
Otsuka Pharmaceutical Development & Commercialization, Inc.$42K
Sunovion Pharmaceuticals Inc.$20K

What the payments were for

Consulting fees$12,24578%
Travel & lodging$1,67211%
Food & beverage$1,82712%
Education$10%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Adlon Therapeutics L.p.	5	$8,554
Takeda Pharmaceuticals U.S.A., Inc.	10	$2,353
Corium, LLC	16	$2,332
Roche Products Limited	4	$1,489
Tris Pharma Inc	25	$564
Ironshore Pharmaceuticals Inc.	10	$171
Neos Therapeutics, LP	8	$132
Supernus Pharmaceuticals, Inc.	6	$122
Arbor Pharmaceuticals, Inc.	2	$27
Travere Therapeutics, Inc.	1	$1

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few developmental - behavioral pediatrics providers in Arizonato place this figure against a meaningful peer group, so we don't.

Other developmental - behavioral pediatrics in Scottsdale

Anna DeocampoScottsdale$13K
Charissa Pe BenitoScottsdale$5K
Agnes BilogScottsdale$1K
Victoria Sheppard-LabrecqueScottsdale$817
Shabana JessaniChandler$31K
Sydney RiceTucson$4K
Dannah RazPhoenix$2K
Catherine RileyTucson$514
Kevin AranasTucson$165
Kanchana BoseroyTucson$147

See the full list for Arizona →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →